Total: 5 |
|
PMID (PMCID) | ||
---|---|---|
26002963 |
MALE | Adult |
How I treat Waldenstrom macroglobulinemia. | ||
Treon SP. Blood. 2015;126(6):721-32. |
||
Patients with disease-related hemoglobin <10 g/L, platelets <100 10(9)/L, bulky adenopathy and/or organomegaly, symptomatic hyperviscosity, peripheral neuropathy, amyloidosis, cryoglobulinemia, cold-agglutinin disease, or transformed disease should be considered for therapy. | ||
19097173 |
MALE | Middle Aged |
Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab. | ||
Ruch J, McMahon B, Ramsey G, Kwaan HC. Am J Hematol. 2009;84(2):120-2. |
||
Unlike previous reports of patients with cryoglobulinemia and cold agglutinin disease, our patient did not have a detectable cryoprecipitate when his cold agglutinin manifested. | ||
19097173 |
MALE | Middle Aged |
Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab. | ||
Ruch J, McMahon B, Ramsey G, Kwaan HC. Am J Hematol. 2009;84(2):120-2. |
||
Cold agglutinin disease occurring with cryoglobulinemia is a rare occurrence. | ||
15495242 |
MALE | Adult |
Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases. | ||
Mantadakis E, Danilatou V, Stiakaki E, Kalmanti M. Am J Hematol. 2004;77(3):303-10. |
||
Rituximab appears safe and modestly effective in a variety of immune-mediated hematologic diseases, including autoimmune hemolytic anemia, chronic immune thrombocytopenia, Evans syndrome, pure red cell aplasia, mixed type II cryoglobulinemia, cold agglutinin disease, and Waldenstrom's macroglobulinemia. | ||
10342051 |
MALE | |
Severe cold agglutinin disease and cryoglobulinemia secondary to a monoclonal anti-Pr2 IgM lambda cryoagglutinin. | ||
Ciejka JZ, Cook EB, Lawler D, Martin J, Woodson RD, Graziano F. Clin Exp Rheumatol. 1999;17(2):227-31. |
||
To present a case of cold agglutinin disease/cryoglobulinemia secondary to a monoclonal anti-Pr2 IgM lambda antibody, and review the literature on the occurrence of this antibody in cold-induced disease and the clinical disease associated with it. |